DMD (BELFAST) LTD

Company number NI678205 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

DMD (BELFAST) LTD - Analysis Report

Company Number: NI678205

Analysis Date: 2025-07-29 19:53 UTC

Financial Health Assessment for DMD (BELFAST) LTD as of 30 April 2024


1. Financial Health Score: D (Concerning)

Explanation:
The company exhibits critical symptoms of financial distress, notably a substantial working capital deficit and sharply increased current liabilities compared to current assets. While the company maintains tangible fixed assets and a small positive net asset position, the liquidity strain and negative net current assets weigh heavily on its short-term financial stability.


2. Key Vital Signs (Core Metrics and Interpretation)

Metric Value (2024) 2023 Value Interpretation
Current Assets £222,268 £186,003 Moderate increase, mainly cash
Cash on Hand £124,309 £69,277 Positive sign, cash nearly doubled
Debtors (Receivables) £47,979 £75,636 Decreased, potential collection issues
Current Liabilities £585,786 £154,849 Massive increase, major liquidity risk
Net Current Assets (Working Capital) -£363,518 £31,154 Large negative value; indicates cash flow stress
Fixed Assets (Net Book Value) £367,578 £16,051 Significant asset acquisition
Net Assets £1,288 £47,205 Sharp decline, minimal equity buffer
Share Capital £1 £1 Nominal share capital
Provisions for Liabilities £2,772 £0 New liabilities recognized

Interpretation of Vital Signs:

  • Liquidity (Cash & Working Capital): Although cash balances have increased, current liabilities have more than tripled, creating a severe working capital deficit. This is akin to a patient having a strong heartbeat (cash) but suffering from blocked arteries (high short-term debts) restricting blood flow (liquidity).
  • Asset Base: The company has invested heavily in fixed assets (likely property, plant, or equipment), which is a positive sign for long-term capacity but these assets are illiquid and do not improve short-term solvency.
  • Equity Position: The drastic drop in net assets from £47k to just over £1k signals erosion of the financial safety net. The company is barely above insolvency territory.
  • Debtor Reduction: Lower receivables could be positive if due to better collections, but if caused by declining sales, it is a red flag.

3. Diagnosis: Financial Condition Analysis

Symptoms of Distress:

  • Severe Working Capital Deficiency: Negative net current assets of -£363,518 represent a critical symptom of liquidity distress. The company may struggle to meet its short-term obligations despite having cash reserves, as current liabilities far exceed current assets.
  • Rapid Increase in Short-Term Debt: Current liabilities surged from £154,849 to £585,786 within one year, largely due to amounts owed to group undertakings (£380,653) and increased tax/social security payables. This may indicate reliance on intercompany financing and tax arrears accumulation.
  • Eroded Equity Cushion: The sharp drop in shareholders' funds from £47,205 to £1,288 signals accumulated losses or write-downs, weakening the company's solvency and financial resilience.
  • Asset Investment Strategy: Large fixed asset additions (£364k) may be a strategic move to support future growth, but this investment has not yet translated into improved liquidity or profitability. The risk is that capital is tied up in non-liquid assets while short-term obligations mount.

Overall Diagnosis:
DMD (BELFAST) LTD is currently in a financially precarious state with a liquidity crisis posing an immediate risk to operational continuity. The company’s financial “vital signs” suggest it is struggling to maintain healthy cash flow despite asset growth. The symptoms of distress warrant urgent intervention to prevent a financial “collapse” akin to a patient needing emergency care to restore vital functions.


4. Recommendations: Steps to Improve Financial Wellness

  1. Improve Working Capital Management:

    • Negotiate extended payment terms with creditors, especially intercompany debts, to alleviate short-term cash pressure.
    • Accelerate collection of receivables and review debtor credit terms to improve cash inflows.
    • Implement stringent inventory management to free up cash tied in stock.
  2. Review Financing Structure:

    • Consider restructuring current liabilities, converting short-term debts into longer-term loans to reduce immediate liquidity strain.
    • Explore external funding options or equity injection to strengthen the capital base.
  3. Operational Cash Flow Monitoring:

    • Establish rigorous cash flow forecasting and monitoring to anticipate liquidity gaps and plan accordingly.
  4. Assess Asset Utilization:

    • Evaluate the return on the recent fixed asset investments to confirm alignment with revenue generation and profitability goals.
    • If necessary, consider asset disposals or leasing options to improve liquidity.
  5. Tax and Compliance Review:

    • Address increased taxation and social security liabilities promptly to avoid penalties and further cash drain.
  6. Management and Governance:

    • Engage with financial advisors or turnaround specialists to develop a recovery plan.
    • Maintain transparent communication with stakeholders regarding financial challenges and mitigation measures.

Executive Summary

DMD (BELFAST) LTD is currently experiencing significant liquidity stress characterized by a large working capital deficit and a sharp rise in current liabilities, placing the company in a financially vulnerable position despite recent fixed asset investments. Immediate actions to improve cash flow management, restructure short-term debt, and strengthen equity are critical to restoring financial health and ensuring ongoing operational viability.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.